Evidence map›Paper›PMID 39058030›Full record

ArticleMicrobiology spectrum2024

A new dynamic

Liangyan Fang, Yunqian Qiao, Xiuting Li, Changbin Wang, Chunqiao Li, Tongqing Luan, Wenqing Wang

Abstract read
In one paragraph

Article in Microbiology spectrum, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Liangyan FangShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.ORCID 0000-0003-2033-5572
Yunqian QiaoShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.
Xiuting LiShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.
Changbin WangShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.
Chunqiao LiShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.
Tongqing LuanShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.
Wenqing WangShandong Institute of Medical Device and Pharmaceutical Packaging Inspection, Jinan, Shandong, China.ORCID 0009-0008-3552-6340

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Central venous catheters (CVCs) are widely used for intravenous medication administration. However, biofilm formation along the catheter surface is the main most important cause of catheter-related bloodstream infections. Nowadays, several antimicrobial-coated catheters are available to prevent biofilm development. In this study, we introduced a new dynamic

Indexed as

Anti-Bacterial AgentsBiofilmsCatheter-Related InfectionsCentral Venous CathetersStaphylococcus aureusStaphylococcus epidermidisHumansMicrobial Sensitivity TestsRifampinAnti-Bacterial AgentsRifampinantimicrobialbiofilm inhibitionbloodstream infectioncentral venous catheterin vitro model

Identifiers

PMID39058030
PMCPMC11370253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.